EGFR and astrocytoma (excluding glioblastoma): However, although without explicitly testing the 3 genetic parameters (TERT promoter mutation, EGFR gene amplification, combined + 7/ − 10 signature) in formerly WHO grade II and III IDH-wildtype astrocytomas which have been deleted in the current WHO classification, the resulting diagnostic failure should be small.